New cellular therapy offers hope for multiple myeloma patients

UChicago Medicine is the first program in Chicago to offer Abecma, a cell-based gene therapy for patients with treatment-resistant multiple myeloma.

Many women have never heard of vulvar cancer. Here's what a survivor would like you to know
New discoveries reveal how acute myeloid leukemia walks a fine line between growth and cell death